Tue, Dec 23, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

Advent's Geneva 8.5 empowers global hedge fund industry

Tuesday, May 24, 2011
Advent Software, Inc., a leading provider of software and services for the global investment management industry, today unveiled a major new release of Geneva®, Advent’s award-winning global portfolio management and fund accounting solution. With the 8.5 enhancements, Geneva is one of the only solutions available that provides portfolio through fund and investor-level accounting on a single platform and extends the product’s portfolio management functionality into the front- and middle-office, making it a compelling offer for alternative investment firms worldwide.

Geneva® 8.5 includes integrated solutions that meet the needs of new market segments, including family offices, private equity firms and fund-of-funds, and are available on a single platform to help simplify operations and reduce total cost of ownership. By extending capabilities into the front-office, Geneva® makes real-time data accessible to traders and portfolio managers, providing increased transparency and enabling informed investment decisions.

Key enhancements to Geneva® include:

  • Real-time P&L and exposure views that allow firms to make important, strategic business decisions without delay
  • Simplified tools to easily build, customize, and deploy dashboards and reports
  • Unparalleled data access and the ability to deliver exceptional client service using industry-standard reporting tools
  • Private equity support, including capital commitment and call processing, waterfall calculations and capital distributions, which enable firms to increase their diversification of funds
  • n-Tier fund structure support, to make it easier to set-up and manage complicated, multi-tiered fund structures
  • Fully integrated investment and investor accounting support on a single platform, which lowers total cost of ownership by reducing operational overhead typically required to maintain and integrate disparate systems
“We see an increasing convergence between private equity and hedge funds, with more managers offering both types of investment structures,” said Bob Schwartz, chief technology officer, GlobeOp Financial Services. “Our technology platform is both a distinct competitive advantage and a source of confidence for our clients. As the only industry accounting product that facilitates investor statements that reflect both hedge fund and equity investments, Geneva 8.5 can play an important role as we support our clients’ changing needs.”

“We simplify the processing and management of complex assets so firms can stay focused on making the best investment decisions for their clients,” said Todd Gottula, Senior Vice President and General Manager of Global Accounts at Advent. “Geneva 8.5 is another milestone in our ongoing effort to develop and deliver a complete portfolio management solution to help professionals at every level, at all types of firms, be successful.”

Source

Press Release
BC

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its